Inactive Instrument

Sector Chart OKYO Pharma Limited London S.E.

Equities

OKYO

GG00BMFG5F62

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
89.87B
37.57B
32.75B
26.47B
14.25B